Peter G. Schulam, MD, PhD, is the Chief Scientific Officer, Johnson & Johnson MedTech. In this role, Dr. Schulam works across the J&J MedTech, medical, and scientific communities to develop real-world policies, practices and technologies that improve outcomes for patients. Additionally, he leads the Global MedTech Regulatory Affairs organization and serves as co-chair of the Johnson & Johnson Data Science Council (JJDSC).

Prior to joining Johnson & Johnson, Schulam served as Chair of the Department of Urology at Yale School of Medicine and Chief of the Department of Urology at Yale New Haven Hospital. During this time, he was a professor of both urology and surgery and nationally recognized as a clinician for his expertise in minimally invasive surgery, robotics and telesurgery. He served as Interim Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital from September 2015 through December 2016. Schulam co-founded the Yale University Center for Biomedical and Interventional Technology, an interdisciplinary initiative to foster greater innovation in medical technology by catalyzing medical device innovation, improving clinical efficiency and efficacy, and lowering healthcare costs. In June 2018, he was named Chief Innovation and Transformation Officer at Yale New Haven Health System.

Prior to joining Yale, Schulam was the Henry E. Singleton Professor of Urology at the Ronald Reagan Medical Center at University of California, Los Angeles, where he served as Vice Chair of Urology, Chief of the Division of Endourology and Minimally Invasive Surgery, and Director of the Surgical Living Kidney Donor program. He was a recipient of the Medical Scientist Training Program Award and received his Medical Degree, as well as his Ph.D., in Immunology at Baylor College of Medicine in Houston. He completed his urology residency at The Johns Hopkins Hospital in Baltimore, Maryland. Having received more than $17 million in grants throughout his career, Schulam is known for his research. He holds multiple patents, has more than 90-peer reviewed publications, contributed chapters to 14 books and has presented and lectured at more than 150 medical meetings around the world.